Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease
Dina Visca (Mantova, Italy), Dina Visca, Sharon Fleming, Ashi Firouzi, Morag Farquhar, Nicholas Hopkinson, Charlotte Hogben, Winston Banya, Paul Cullinan, Angelo De Lauretis, Maria Kokosi, John Tayu Lee, Rosemarie Lyne, Sarah Agnew, Apollo Kwok, Surinder Birring, Alfredo Chetta, Anne Marie Russell, Peter Saunders, Toby Maher, Athol Wells, Lisa Spencer, Elisabetta Renzoni
Source: International Congress 2016 – Clinical aspects of ILD
Session: Clinical aspects of ILD
Session type: Thematic Poster
Number: 797
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dina Visca (Mantova, Italy), Dina Visca, Sharon Fleming, Ashi Firouzi, Morag Farquhar, Nicholas Hopkinson, Charlotte Hogben, Winston Banya, Paul Cullinan, Angelo De Lauretis, Maria Kokosi, John Tayu Lee, Rosemarie Lyne, Sarah Agnew, Apollo Kwok, Surinder Birring, Alfredo Chetta, Anne Marie Russell, Peter Saunders, Toby Maher, Athol Wells, Lisa Spencer, Elisabetta Renzoni. Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease. Eur Respir J 2016; 48: Suppl. 60, 797
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study Source: Eur Respir J 2006; 27: 697-704 Year: 2006
Effective delivery of ambulatory oxygen in interstitial lung disease- a crossover trial Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2016
An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases Year: 2015
AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease? Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015
Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis – A randomized, controlled trial Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases Year: 2016
Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009
Effect of hyperoxia on exercise performance in COPD: Randomized trial Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Exercise training improves exercise capacity and quality of life in people with dust-related pleural and interstitial respiratory diseases: A randomised controlled trial Source: Annual Congress 2011 - Exercise training: new populations, new techniques Year: 2011
Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial. Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2021
Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial Source: Eur Respir J 2010; 35: 571-577 Year: 2010
Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019 Year: 2019
The influence of lung volume reduction surgery on exercise in patients with COPD Source: Eur Respir J 2004; 23: 269-274 Year: 2004
Effects of additional manual therapy over inspiratory muscle training in patients with chronic obstructive pulmonary disease: A randomized controlled trial Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015
Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004
Randomized controlled trial of abituzumab in systemic sclerosis-associated interstitial lung disease Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017
Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial Source: ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020 Year: 2020